Power Up Your Morning with iBIO NewsBrief!
Get the daily email that keeps you informed and connected in the life sciences industry
📲 READ THE LATEST NEWSLETTER
iBIO IN THE NEWS
iBIO President & CEO Rings NYSE Closing Bell with CSBA Leadership
New Report Explores Latest Best Practices in State Bioscience Economic Development Initiatives
Drug manufacturer to open $50 million site in Rockford – Crain’s Chicago Business
How a budding life-sciences sector may impact Chicago real estate in 2023 – Chicago Business Journal
PRESS RELEASES AND BLOGS
iBIO Announces 2025 iCON Awards Winners Honoring Illinois Life Sciences Leaders
GBG September Grant Opportunities for iBIO Members
iBIO Leads 74-Organization Coalition Urging Illinois Congressional Delegation to Reauthorize SBIR Program
G2G August Grant Report: 78 Non-Dilutive Funding Opportunities for iBIO Members
MEMBER NEWS
Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development
Capital Pulse: Flow Medical Secures $5M Seed Round, Including First-Ever UCM Ventures Investment
The Growing Crisis of Antimicrobial Resistance: Meitheal Takes Action with XENLETA®
COUR Pharmaceuticals and Genentech Strike $900M+ Deal for Autoimmune Disease Treatment
POLICY NEWS
iBIO Joins AdvaMed Coalition Pushing for Faster Medicare Coverage of Medical Devices
iBIO Leads 74-Organization Coalition Urging Illinois Congressional Delegation to Reauthorize SBIR Program
Illinois Life Sciences Companies Urged to Sign Group Letter Supporting SBIR/STTR Reauthorization
Illinois companies stand to lose $90 million in annual funding if federal programs expire September 30th Illinois life sciences companies and associations have until August 15th to sign onto a group letter urging the state’s Congressional Delegation to reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs before their September […]
Statement from John Conrad on the President’s Most Favorite Nation Announcement
ALL NEWS
Abbott’s $21B Exact Sciences Buy Marks a Big Bet on Cancer Screening
Abbott confirmed a $21 billion deal to acquire Exact Sciences, instantly becoming one of the...
This Month’s GBG Report: Non-Dilutive Funding Opportunities (November 2025)
Even with Washington hitting the pause button during the federal shutdown, this month’s GBG Report...
Illinois Life Sciences Community Celebrates Innovation at the 2025 iCON Awards
The Illinois life sciences community gathered last Thursday evening at The Salt Shed’s Three Top...
iBIO Announces 2025 iCON Awards Winners Honoring Illinois Life Sciences Leaders
iBIO (Illinois Biotechnology Innovation Organization) is proud to announce the winners of the...
Setting the Record Straight on 340B in Illinois
There’s been a lot of misinformation circulating about the 340B Drug Pricing Program and HB2371 in...








